Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.06B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.87B |
| 3 |
Apple
AAPL
|
+$1.03B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$747M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$730M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$930M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$598M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$524M |
| 4 |
TSMC
TSM
|
+$363M |
| 5 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.47% |
| 2 | Healthcare | 9.44% |
| 3 | Financials | 9.02% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Oppenheimer Holdings
OPY
$1.2B
| $9.02M | ﹤0.01% |
291,204
-67,873
| -19% | -$2.37M |
|
|
VBTX
2577
DELISTED
Veritex Holdings
VBTX
| $9.02M | ﹤0.01% |
339,049
+198,184
| +141% | +$6M |
|
2578
PUT
Goodyear
GT
$1.85B
| $8.99M | ﹤0.01% |
890,800
+300,000
| +51% | +$3.81M |
|
2579
Sprout Social
SPT
$621M
| $8.97M | ﹤0.01% |
147,888
-4,905
| -3% | -$295K |
|
2580
Heartland Express
HTLD
$956M
| $8.97M | ﹤0.01% |
626,920
+189,505
| +43% | +$2.85M |
|
2581
Nomura Holdings
NMR
$29.1B
| $8.97M | ﹤0.01% |
2,717,018
-1,115,654
| -29% | -$4.05M |
|
|
CTIC
2582
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $8.94M | ﹤0.01% |
1,535,544
+887,948
| +137% | +$5.53M |
|
2583
iShares US Telecommunications ETF
IYZ
$1.26B
| $8.93M | ﹤0.01% |
427,523
+209,774
| +96% | +$5.23M |
|
|
UNIT
2584
Uniti Group
UNIT
$2.32B
| $8.9M | ﹤0.01% |
1,280,821
+949,523
| +287% | +$8.82M |
|
|
CIM
2585
Chimera Investment
CIM
$1B
| $8.9M | ﹤0.01% |
568,373
-134,975
| -19% | -$3.51M |
|
|
HCAR
2586
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
| $8.88M | ﹤0.01% |
894,449
+20,082
| +2% | +$199K |
|
|
TELL
2587
DELISTED
Tellurian Inc.
TELL
| $8.87M | ﹤0.01% |
3,709,928
+335,358
| +10% | +$1.21M |
|
2588
Vertiv
VRT
$105B
| $8.86M | ﹤0.01% |
911,431
-584,728
| -39% | -$6.57M |
|
2589
PUT
State Street SPDR S&P Bank ETF
KBE
$1.66B
| $8.86M | ﹤0.01% |
+200,000
| New | +$9.51M |
|
2590
Kulicke & Soffa
KLIC
$4.78B
| $8.86M | ﹤0.01% |
229,861
-138,537
| -38% | -$6.13M |
|
|
RWT
2591
Redwood Trust
RWT
$594M
| $8.84M | ﹤0.01% |
1,540,492
+564,784
| +58% | +$4.37M |
|
|
OSG
2592
Octave Specialty Group
OSG
$222M
| $8.83M | ﹤0.01% |
692,557
-674,743
| -49% | -$8.99M |
|
2593
uniQure
QURE
$3.22B
| $8.83M | ﹤0.01% |
470,482
+67,551
| +17% | +$1.42M |
|
2594
Nabors Industries
NBR
$1.21B
| $8.82M | ﹤0.01% |
86,965
+31,202
| +56% | +$3.82M |
|
|
MYOV
2595
DELISTED
Myovant Sciences Ltd.
MYOV
| $8.82M | ﹤0.01% |
491,162
+72,826
| +17% | +$1.16M |
|
2596
Gaotu Techedu
GOTU
$436M
| $8.79M | ﹤0.01% |
7,263,339
+1,665,334
| +30% | +$2.69M |
|
|
AMED
2597
DELISTED
Amedisys
AMED
| $8.78M | ﹤0.01% |
90,736
+17,030
| +23% | +$2.03M |
|
2598
Fox Factory Holding Corp
FOXF
$886M
| $8.74M | ﹤0.01% |
110,581
+3,702
| +3% | +$343K |
|
|
RETA
2599
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $8.74M | ﹤0.01% |
347,730
+271,475
| +356% | +$7.52M |
|
2600
LSB Industries
LXU
$693M
| $8.72M | ﹤0.01% |
612,124
+174,807
| +40% | +$2.47M |
|
Similar funds
Goldman Sachs's Q3 2022 Portfolio in Review
As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.
- Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
- Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
- Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
- Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
- Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
- Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
- Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.